🔎 Trials Near Me

Dachaigh › Lymphoma Cealla Mantle › North Carolina › Charlotte

Sgrùdaidhean clionaigeach Lymphoma Cealla Mantle ann an Charlotte, NC

Tha 5 sgrùdaidhean airson Lymphoma Cealla Mantle a’ lorg phàirtichean aig làraichean ann agus timcheall air Charlotte (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

A’ fastadhÌre 1/2
  • Research Site, Charlotte
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06542250

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

A’ fastadhÌre 3
  • Atrium Health Levine Cancer Institute (Lci), Charlotte
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06742996

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

A’ fastadhÌre 1/2
  • Research Site, Charlotte
  • Research Site, Charlotte
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06564038

A Study of ARC-02 in B-cell NHL

A’ fastadhÌre 1
  • Levine Cancer Institute, Charlotte
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT07691606

BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

A’ fastadhÌre 1
  • Atrium Health Levine Cancer Institute - Morehead, Charlotte
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Samh 2025 · NCT05370430

Sgrùdaidhean Lymphoma Cealla Mantle ann am bailtean eile

Sgrùdaidhean eile ann an Charlotte

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.